Home » Topics » BioWorld Science

BioWorld Science
RSS

Lymph dysfunction identified as potential metabolic target

Sep. 23, 2021

VaxEquity collaborates with AstraZeneca to progress saRNA platform technology

Sep. 23, 2021

Seed funding at Opus Genetics supports progression of programs in Leber congenital amaurosis

Sep. 23, 2021

MDL-001 shown to protect mice against COVID-19-mediated weight loss

Sep. 23, 2021

AbCellera and Everest Medicines collaborate to discover therapeutic antibodies

Sep. 23, 2021

Rosalind Franklin University and Aptinyx collaborate on therapeutics for brain and CNS disorders

Sep. 23, 2021

Hexagon Bio raises funds to advance preclinical pipeline in oncology and infectious diseases

Sep. 23, 2021

BiVictriX completes two antibody discovery campaigns in support of BVX-001

Sep. 23, 2021

OncoNano expands research collaboration with UTSW on novel cancer therapeutics

Sep. 23, 2021

Characterization of potent and selective inhibitors of BET BD2

Sep. 23, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...